Forum Financial Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $366K | Sell |
698
-132
| -16% | -$69.3K | 0.01% | 550 |
|
|
2025
Q1 | $526K | Sell |
830
-86
| -9% | -$54.5K | 0.01% | 344 |
|
|
2024
Q4 | $652K | Buy |
916
+110
| +14% | +$78.4K | 0.01% | 299 |
|
|
2024
Q3 | $847K | Sell |
806
-1
| -0.1% | -$1.05K | 0.01% | 209 |
|
|
2024
Q2 | $848K | Buy |
807
+2
| +0.2% | +$2.1K | 0.02% | 200 |
|
|
2024
Q1 | $775K | Sell |
805
-2
| -0.2% | -$1.93K | 0.01% | 228 |
|
|
2023
Q4 | $709K | Buy |
807
+224
| +38% | +$197K | 0.01% | 212 |
|
|
2023
Q3 | $480K | Hold |
583
| – | – | 0.01% | 290 |
|
|
2023
Q2 | $419K | Buy |
583
+6
| +1% | +$4.31K | 0.01% | 331 |
|
|
2023
Q1 | $474K | Buy |
577
+9
| +2% | +$7.4K | 0.01% | 278 |
|
|
2022
Q4 | $410K | Sell |
568
-18
| -3% | -$13K | 0.01% | 301 |
|
|
2022
Q3 | $404K | Sell |
586
-320
| -35% | -$221K | 0.02% | 270 |
|
|
2022
Q2 | $536K | Buy |
906
+89
| +11% | +$52.7K | 0.03% | 220 |
|
|
2022
Q1 | $570K | Buy |
817
+59
| +8% | +$41.2K | 0.03% | 218 |
|
|
2021
Q4 | $479K | Buy |
+758
| New | +$479K | 0.02% | 261 |
|